Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Above averageSolventum Corporation ("Solventum," "we," "our," "us," or the "Company"), is a leading global healthcare company developing, manufacturing, and commercializing a broad portfolio of solutions that leverages deep material science, data science, and digital capabilities to address critical customer and patient needs. We constantly seek to enable the improvement of standards of care and move healthcare forward with innovation powered by insights, clinical intelligence, technology, and manufacturing expertise.
In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR
Business segments
Q2 2026 · $1.29BThe company’s own SEC segment disclosure.
- Med Surg$537.0M42%
- Dental Solutions$396.0M31%
- Health Information Systems$354.0M28%
Solventum (SOLV) reported revenue of $2.21B in Q2 2026 (quarter ended June 30, 2026), up 2.2% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $92M (4.2% of revenue). For the full year FY2025, revenue was $8.32B (+0.9% year on year) and net income $1.56B. Its largest segment in 2026-Q2 was Med Surg at $537M, 42% of the disclosed total, just ahead of Dental Solutions at 31%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Medical Instruments & Supplies
Ranks #5 of 27 by Smart Score